Wargacki Stephen
SEC CIK 1960165 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AQST | Aquestive Therapeutics, Inc. | SVP, Research, Development | 363.6K | — | — | 8 | 2023-03-09 | 2025-03-07 |
Most active insiders at AQST, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Barber Daniel | Pres, CEO, Dir | — | $1.77M |
| 2 | Jung Cassie | COO | — | $664.6K |
| 3 | Boyd Peter E. | See Remarks | — | $257.3K |
| 4 | TOTH A ERNEST JR | CFO | — | $242.9K |
| 5 | BRAENDER LORI J | Corp. Sec | — | $167.2K |
| 6 | Kraus Carl N | Chief Medical Off | — | $141.9K |
| 7 | Krop Julie | Dir | — | $125.4K |
| 8 | Korczynski Sherry | Chief Commercial Off | — | $111.3K |
| 9 | Cioffi Melina | SVP, Regulatory Affairs | — | $105.5K |
| 10 | Zalewski Thomas A. | CLO | — | — |
Wargacki Stephen made no open-market trades at AQST in the last 12 months.
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-11 | 2025-03-07 | AQST | Aquestive Therapeutics, Inc. | Wargacki Stephen | CSO | A - Grant | $0.00 | +115.0K | 376.4K | +44% | $0 |
| DM | 2025-03-11 | 2025-03-07+ | AQST | Aquestive Therapeutics, Inc. | Wargacki Stephen | CSO | F - Tax | $2.63 | -32.9K | 363.6K | -8% | -$86.6K |
| A | 2024-10-02 | 2024-03-09 | AQST | Aquestive Therapeutics, Inc. | Wargacki Stephen | CSO | F - Tax | $4.88 | -19.5K | 261.4K | -7% | -$95.2K |
| 2024-05-13 | 2024-05-10 | AQST | Aquestive Therapeutics, Inc. | Wargacki Stephen | CSO | A - Grant | $0.00 | +10.0K | 268.0K | +4% | $0 | |
| M | 2024-03-12 | 2024-03-09+ | AQST | Aquestive Therapeutics, Inc. | Wargacki Stephen | SVP, Research, Development | F - Tax | $4.88 | -13.0K | 258.0K | -5% | -$63.2K |
| D | 2024-03-11 | 2023-03-10 | AQST | Aquestive Therapeutics, Inc. | Wargacki Stephen | SVP, Research, Development | F - Tax | $0.79 | -1,981 | 158.4K | -1% | -$1,565 |
| D | 2024-03-11 | 2024-03-07 | AQST | Aquestive Therapeutics, Inc. | Wargacki Stephen | SVP, Research, Development | A - Grant | $0.00 | +112.5K | 270.9K | +71% | $0 |
| 2023-03-09 | 2023-03-09 | AQST | Aquestive Therapeutics, Inc. | Wargacki Stephen | SVP, Research, Development | A - Grant | $0.00 | +135.0K | 162.0K | +501% | $0 |
Purchase Sale Sale after option exercise All abbreviations